Hawaii ALS and Neuromuscular Center Selected for ADAPT-EARLY Clinical Trial in Generalized Myasthenia Gravis (gMG)
The Hawaii ALS and Neuromuscular Center has been selected to participate in the ADAPT-EARLY clinical trial, a Phase 4 research study evaluating efgartigimod PH20 SC in adults with new-onset generalized myasthenia gravis (gMG). This important study focuses on early treatment intervention for individuals diagnosed with gMG within the past year . What Is Generalized Myasthenia […]



